Long-term Survivorship Challenges of Advanced/Metastatic GIST Patients Responding to Tyrosine Kinase Inhibitor Treatment: an Observational Study

NCT07522762 · clinicaltrials.gov ↗
RECRUITING
Status
330
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

The Netherlands Cancer Institute

Collaborators